Sveriges mest populära poddar

Pharmaceutical Executive Daily: September 25, 2025

3 min•25 september 2025

In today’s Pharmaceutical Executive Daily, we cover Glenmark’s billion-dollar exclusive licensing deal with Hengrui, Harmony Biosciences’ trial setback for Zygel, and the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations.

Fler avsnitt av Pharmaceutical Executive

Pharmaceutical Executive Daily: AI as Reinvention

8 juli•3 min

“AI as Reinvention”: Transforming the Business of Medicine

8 juli•35 min

Pharmaceutical Executive Daily: The Changing Reality of Pharmaceutical Commercialization

7 juli•3 min

Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge

1 juli•3 min

Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program

30 juni•3 min

Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics

29 juni•4 min

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

25 juni•3 min

Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

24 juni•3 min

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

23 juni•4 min

Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

22 juni•3 min

Pharmaceutical Executive med Pharmaceutical Executive Podcast finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.